Artrya Limited Stock Price

ASX:AYA Community·AU$559.3m Market Cap

0 Narratives written by author
0 Comments on narratives written by author
13 Fair Values set on narratives written by author

Create a narrative

AYA Share Price Performance

AU$3.54

3.09 (686.67%)

AU$3.54

3.09 (686.67%)

AU$3.54

Mon, 17 Nov 25

Share Pricen/a

AYA Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Snowflake Analysis

Flawless balance sheet with high growth potential.

4 Risks

1 Reward

View Full Analysis

Artrya Limited Key Details

Last Reported Earnings

Jun 30, 2025

Next Reporting Earnings

n/a

: -0.10
: -57,103.57%
: -58,592.86%
: 0%

View Full Analysis

About AYA

Founded: 2018
Employees: n/a
CEO: John Konstantopoulos
WebsiteView website: www.artrya.com

Artrya Limited, a medical technology company, engages in the development and commercialization of artificial intelligence platform that detects, diagnoses, and address coronary artery disease in Australia. The company offers Salix, a suite ifcloud-based software that uses artificial intelligence to automate the detection of coronary artery disease from coronary computed tomography angiography scans to identify and manage patients at risk of a heart attack. Artrya Limited was incorporated in 2018 and is based in West Perth, Australia.